Categories Earnings, Health Care

Titan Pharmaceuticals, Inc. (TTNP): Q4 2019 Earnings Snapshot

Earnings Update by AlphaStreet

— Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in line with Wall Street expectation.

— Q4 revenue was flat at $1.2 million, vs. $920,000 expected.

— As at December 31, 2019, Titan had cash and cash equivalents of approximately $5.2 million.

— Launch of Sixmo may be delayed due to the impact of Covid-19.

— TTNP shares gained 4.4% during after-market trading hours.

Also Read:  Key highlights from CrowdStrike (CRWD) Q2 2021 earnings results

Most Popular

COVID-19 drove retailers up the digital path years ahead than anticipated

Earlier we looked into how, during the COVID-19 pandemic, retailers saw changing trends in terms of their assortments and how the acceleration of online shopping led many of them to

Snowflake (SNOW) creates a record as the most successful software IPO ever; stock more than doubles

Data is at the heart of business innovation. Recognizing this trend, companies are seeking ways to transform their businesses by capturing, analyzing, and mobilizing data. The public cloud is becoming

Adobe (ADBE) sees new tailwinds as virtual shift gathers steam

The second half has been highly rewarding for design software maker Adobe Inc. (NASDAQ: ADBE) amid stable demand for digital content solutions. The company has remained unaffected by the virus-related

Top